Impilo acquires Qufora in partnership with existing shareholders
September 2nd, 2024
Impilo, a leading Nordic investment company specializing in healthcare, has acquired Qufora in partnership with the existing shareholders.
Nicholas Hooge, Partner at Impilo, says about the investment:
“We have followed Qufora for several years and are highly impressed by the company’s development, which is largely grounded in Qufora’s strong values, strategy, and culture. This is encapsulated by a highly skilled management team and staff who show a deep passion for Qufora’s products and mission. With this partnership, we can jointly accelerate the company’s future expansion.”
Lena Ehmsen Lachenmeier, CEO of Qufora A/S adds:
“Through this investment and with Impilo as part of our ownership, we have gained an experienced healthcare investor who will provide us with a strong and steady hand in executing our strategy. This means we can continue to develop groundbreaking products and services which enable people with chronic bowel disorders to live a better life.”
As a result of Impilo’s investment in Qufora, a new board of directors will be appointed, with Mikael Worning as Chairman. Mikael has had a long career in the medtech industry, holding several top executive positions at Demant, as well as board positions at Ambu, 3Shape, Tandlægen.dk, and Cellavision.
With Impilo as investor and partner, Qufora is ready to take the next step in its expansive business strategy, which has already earned the company a strong market presence in Europe and broad recognition for its user-centered innovations.
Qufora was founded in 2006 by a group of medtech industry specialists:
“It is with immense pride that we can now pass the torch of this company. There is a strong entrepreneurial spirit in Qufora, and a very special company culture with a deep commitment to the users. I am confident that this unique dedication and identity will continue in our partnership with Impilo,” says Christian Dorfelt, one of Qufora’s original founders.
Pictured above are Nicholas Hooge – Partner at Impilo, Lena Ehmsen Lachenmeier – CEO at Qufora A/S, Mikael Worning – Chairman of the Board, and Michael Sorth – CFO at Qufora A/S.
Mission, vision & values
The cornerstones of our business.
Our vision, mission and values are centered around health.
Bowel irrigation
Bowel irrigation – sometimes called transanal irrigation (TAI) or rectal irrigation (RI) has been practiced for many hundreds of years.
Understanding bowel irrigation
Bowel irrigation simply involves instilling warm tap water into the rectum via the anus to help emptying the colon.
Imagine the possibilities
Discover Qufora IrriSedo Flow, a new bowel irrigation system with an innovative way of managing water flow, that is simply intuitive to use and designed to be individual to suit different situations.